InvestorsHub Logo

agrav

07/28/10 4:14 PM

#907 RE: wkpeters #905

This "research' is paid for by the company.

Just read the fine print at the bottom. I found the guy's real job and client list that includes iMedicor and Access Pharma.

http://www.proactivenewsroom.com/clients/

Looks like he could have been paid in shares - so we have one more dumper lined up for January. 75K is 1.5M Shares?

OIR OR AN AFFILIATE OF OIR HAS BEEN/WILL BE OR MAY BE COMPENSATED IN RULE 144 STOCK OF THE COMPANY FOR THE PUBLICATION AND CIRCULATION OF THESE REPORTS. THE MAXIMUM AMOUNT CHARGED BY OIR IS $75,000 IN RULE 144 STOCK PER REPORT. OIR INTENDS TO SELL ALL OR A PORTION OF THE OF THE RULE 144 STOCK IN ACCORDANCE WITH ALL SECURITIES LAWS, WHICH PREVENTS OIR FROM SELLING STOCK FOR A PERIOD OF SIX MONTHS TO ONE YEAR DEPENDING ON THE BULLETIN BOARD AND PINK SHEETS REGULATIONS.

agrav

07/29/10 12:52 PM

#912 RE: wkpeters #905

Peters is 5 star Bullish on ACCP and Bearish on VMCI?

http://www.socialpicks.com/wkpeters

I'm very confused now, please explain.

Warmly

Alyce